Asymmetric dimethylarginine levels are associated with augmentation index across naïve untreated patients with different hypertension phenotypes

Abstract excerpt

Asymmetric dimethylarginine (ADMA) is a robust marker of endothelial dysfunction in patients with essential hypertension. We investigated ADMA levels and their association with vascular damage in untreated hypertension. We enrolled consecutive patients with untreated, recently diagnosed hypertension and age-matched normotensive individuals. 24-hour blood pressure, central hemodynamics, and arterial stiffness were...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Blood Pressure and Hypertension Studies
• Share to Cardiovascular Health and Disease Prevention
• Share to Nitric Oxide and Endothelin Effects